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Abstract 
 
Unstable angina is common clinical manifestation of atherosclerosis. However, the 
detailed pathogenesis of unstable angina is still not known. Here, I propose that 
unstable angina is a mixed TH17 and TH1 immune disorder. By using microarray 
analysis, I find out that TH1 and TH17 related cytokine, cytokine receptor, 
chemokines, complement, immune-related transcription factors, anti-bacterial genes, 
Toll-like receptors, and heat shock proteins are all up-regulated in peripheral 
leukocytes of unstable angina. In addition, H-ATPase, glycolytic genes, platelet and 
RBC related genes are also up-regulated in peripheral leukocytes of during unstable 
angina. It also implies that atherosclerosis is a mixed TH17 and TH1 autoimmune 
disease. If we know the etiology of unstable angina as well as atherosclerosis better, 
we can have better methods to control and prevent this detrimental illness. 
 
Introduction 
 
Atherosclerosis is a very popular disease, especially in developed countries. It is the 
top death-causing disease in industrial countries. Coronary artery disease (CAD) is 
the most important clinical symptom of atherosclerosis. Typical angina and unstable 
angina are common manifestations of CAD. Atherosclerosis is thought to be an 
inflammatory disorder. However, the detailed pathogenesis of angina is not known. 
Here, I use microarray analysis of peripheral leukocytes to describe unstable angina is 
a mixed TH1 and TH17 immune disorder.  
 
Materials and methods 
 
Study samples 
 
I use microarray dataset from Gene Omnibus website (GEO). The dataset serial 
number is GSE. This dataset includes peripheral leukocytes from patients of acute 
myocardial infarction and unstable angina. Here, I compare the RNA expression 
profile of leukocytes from unstable angina patients to that from health normal 
control. This dataset is GSE29111 from Dr. Milo and Rothman’s study group. The 
healthy normal controls are from dataset of a Huntington’s disease blood biomarker 
study population. The dataset is GSE8762 from Dr. Runne H.’s study group. This 
second study was published in PNAS,2007, 104(36):14424. 
 
RMA normalization 
 Affymetrix HG-U133A 2.0 genechip was used in both samples. RMA express 
software(UC Berkeley, Board Institute) is used to do normalization and to rule out the 
outliners of the above dataset. I rule out the potential outliners of samples due to 
the following criteria:  
1. Remove samples which have strong deviation in NUSE plot 
2. Remove samples which have broad spectrum in RLE value plot 
3. Remove samples which have strong deviation in RLE-NUSE mutiplot 
4. Remove samples which exceed 99% line in RLE-NUSE T2 plot 
 
By the exclusion criteria above, I removed GSM721017 from unstable angina samples 
and GSM217774 from healthy normal controls. Then, Genespring XI software was 
done to analysis the significant expressed genes between ARDS and healthy control 
leukocytes. P value cut-off point is less than 0.05. Fold change cut-off point is >2.0 
fold change. Benjamini-hochberg corrected false discovery rate was used during the 
analysis. Totally, a genelist of 6020 genes was generated from the HGU133A2.0 chip 
with 18400 transcripts including 14500 well-characterized human genes. 
 
 
Results 
 
Toll-like receptor up-regulation in unstable angina 
 
During the microarray analysis of peripheral blood leukocytes of unstable angina 
patients, I find out that Toll-like receptor genes are up-regulated.(Table1) These 
genes include TLR 1,2,4,6,8, TIRAP, TTRAP, TRAF6, TANK, TICAM2, and TOLIP. It is 
worth noting that TLR1 is 7 fold up-regulated, TLR4 is 13 fold up-regulated, TLR8 is 6 
fold up-regulated, and TANK is 6 fold up-regulated. Since TLR 1,2,4,6,8 are related to 
the activation of antibacterial TH1 or TH17(TH22) immunity, we can say that 
TH1(anti-intracellular bacteria) or TH17(TH22)(anti-extracellular bacteria) immunity 
is triggered during unstable angina. 
 
Heat shock protein up-regulation in unstable angina 
 
In the peripheral leukocyte of unstable angina patients, mRNAs of many heat shock 
proteins are up-regulated. These genes include HSPA6, HSPA1A/A1B, HSPA13, 
HSPB11, DNAJA4, DNAJB9, DNAJB2, DNAJB4, DNAJC6, DNAJA2, DNAJC27, DNAJC3, 
and DNAJC25. (Table2) Among them, HSPA1A/HSPA1B is 5.6 fold up-regulated and 
DNAJC6 is 4.8 fold up-regulated. However, few certain heat shock protein genes are 
down-regulated including HSP90AA1, DNAJC1, DNAJC2, DNAJC3, and DNAJC7. In 
addition, these genes are only 2-3 fold down-regulated. HSP70 can bind to TLRs to 
initiate anti-bacterial immunity. Thus, anti-bacterial TH1 or TH17(TH22) is likely to be 
activated at unstable angina. 
 
TH1 and TH17 related transcription factor up-regulation during unstable angina 
 
Then, we will look at TH1 and TH22(TH17) related transcription factor regulation 
during unstable angina.(Table 3) TH1 related transcription factors, STAT1, ETS2, RARA, 
RXRA, IRF2, MNDA, MYADM, IDO1, and MMD, are up-regulated during unstable 
angina. Up-regulated TH17 related transcription factors include SMAD1, SMAD4, 
SMAD2, SMAD5, SMAD7, RARA, RXRA, STAT5B, SOCS3, IKZF3, FOSL2, and FOXO3. 
Besides, negative regulator of TH17 immunity, ETS1, is down-regulated in unstable 
angina. In addition, THαβ related transcription factors are down-regulated including 
MAFB, suppressor of IKKe, and BCL6. STAT1 is the key downstream mediator of IFNg. 
ETS2 can up-regulate IL-12 production. Retinoic acid (for RXRA and RARA) can 
promote TH1 and TH17 immunity. IRF2 can promote TH1 immunity via IFNg. IDO is 
the downstream mediator of IFNg. MNDA, MYADM, and MMD are all macrophage 
differentiation factors. SMADs and STAT5B are downstream mediators of TGFb, a key 
cytokine of TH17 immunity. SOCS3, IKZF3, FOSL2, and FOXO3 can all promote TH17 
immunity.  
 
TH1 and TH17 related chemokine up-regulation during unstable angina 
 
In this microarray analysis, we can see many chemokine genes are up-regulated 
during unstable angina. (Table 4) Most important of all, majority of these chemokine 
genes are TH1 and TH17 related chemokines. The up-regulated chemokine as well as 
chemokine receptors include CXCL1, CCR1, CXCL6, CCR2, CCR6, CCR3, DARC, CCL23, 
CCRL2, CXCR7, CXCL5, CKLF, IL8RB, IL8RA, IL8, S100A11, S100B, S100A9, S100P, and 
S100A12. Among these genes, CXCL1 is 8 fold up-regulated, CCR3 is 18 fold 
up-regulated, CXCL5 is 8 fold up-regulated, IL8RB is 38 fold up-regulated, and S100P 
is 50 fold up-regulated. TH1 related chemokine or chemokine receptors include CCR1, 
CCR2, CCR6, CCR3, CCL23, and CXCR7. TH17 related chemokine or chemokine 
receptors include CXCL1, CXCL6, CXCL5, IL8RB, IL8RA, IL8, and S100 proteins.  
 
TH1 and TH17 related prostaglandin and leukotriene during unstable angina 
 
In peripheral leukocytes of unstable angina patients, many prostaglandin and 
leukotriene genes are up-regulated. (Table 5) These up-regulated genes include 
HPGD, PTGS1, PTGS2, LTB4R, ALOX5AP, ALOX5, ALOX12, PLA2G12A, and PLAA. 
Prostaglandin and leukotriene B4 are mainly neutrophil chemoattractants. Thus, 
up-regulation of these genes suggests that TH17 related chemotaxis is up-regulated 
during unstable angina.  
 
TH1 and TH17 related cytokine up-regulation in unstable angina 
 
During unstable angina, many TH1 and TH17 related cytokines are up-regulated. 
(Table 6) Up-regulated TH1 cytokines include TGFA, IL-18(IFNG inducing factor), and 
IFNG. Up-regulated TH17 related cytokines include IL-8 and IL-1B. It is worth noting 
that IL1B is 11 fold up-regulated. Down-regulated cytokines in unstable angina 
include IL-34, IL-23A, IL-32, and TGFB1. It is important to know that IL1 beta is the 
key cytokine in TH17 (TH22) anti-extracellular bacteria immunity. IFN gamma is the 
key enzyme in TH1 anti-intracellular bacteria immunity. Thus, both TH17 and TH1 
immunity are up-regulated during unstable angina. 
 
TH1 and TH17 related cytokine receptor expression in unstable angina 
 
In this microarray study, I find out that many cytokine receptor gene expressions are 
changed during unstable angina. (Table 7) Up-regulated cytokine is usually 
accompanying with down-regulated its cytokine receptor in certain specific 
immunological pathway. Down-regulation of IL-6 receptor (IL-6ST) implies that TH17 
immunological pathway is activated. Down-regulation of IFNg receptor implies that 
TH1 immunological pathway is also activated. Up-regulation of IL-13 and IL-5 
receptors suggest that TH2 immunological pathway is not activated. Up-regulation of 
IL-10 and type 1 interferon receptors suggests that THαβ immunological pathway is 
not activated. Significant up-regulation of IL-1 receptors suggests that TH22 
immunological pathway is not activated. And, up-regulation of TGFB1 receptor 
suggests that Treg pathway is not activated.  
 
Anti-bacterial complement up-regulation during unstable angina 
 
Complements are important for anti-bacterial innate immunity including TH1 and 
TH17 immunity. Here, we show that majority of complement genes are up-regulated 
during unstable angina. (Table 8) These complement genes include CD59, CD55, CFD, 
C4BPA, CR1, C4A/B, CD46, C1QBP, ITGAX, C1RL, C5AR1, and CR1/1L. The only 
down-regulated complement gene is C1QA. It means that the whole complement 
machinery is up-regulated during unstable angina. 
 
Other anti-bacterial related gene up-regulation in unstable angina 
 
In table 9, many other important anti-bacterial genes are up-regulated during 
unstable angina. These genes include CSF3R, FPR1, CSF2RB, SCARF1, CSF2RA, DEFA4, 
NCF4, NCF2, FPR2, MRC2, DEFB106A, and PTX3. It is worth noting that CSF2RB is 10 
fold up-regulated, DEFA4 is 11 fold up-regulated, and FPR2 is 38 fold up-regulated. 
These neutrophil or anti-bacterial related genes suggest the activation of TH1 and 
TH17 host immunological pathways in unstable angina. 
 
Glycolytic genes up-regulation during unstable angina 
 
In table 10, the whole set of glycolytic pathway is up-regulated in unstable angina. 
Hypoxia can drive the activation of the anaerobic glycolysis. Thus, it is reasonable 
that glycolytic enzymes are up-regulated during the hypoxia status of the attack of 
unstable angina. These up-regulated genes include PGK1, PFKFB3, HK2, PYGL, BPGM, 
PDK3, PFKFB2, GAPDH, ENO1, PDK2, PDK4, PGK1, and PFKFB4. It is worth noting that 
BPGM(2,3-bisphosphoglycerate mutase) is 19 fold up-regulated. The product of 
BPGM is 2,3-bisphosphoglycerate, which combines with hemoglobin, can cause a 
decrease in affinity for oxygen. Thus, the presence of 2,3-bisphosphoglycerate helps 
oxyhemoglobin to unload oxygen to help unstable angina patients.  
 
H+-ATPase gene up-regulation during unstable angina 
 
In table 11, we can see many H+-ATPases are up-regulated during unstable angina. 
These genes include ATP6V0B, ATP6V0C, ATP6V1B2, ATP6V0E1, ATP6AP2, ATP6V1A, 
ATP6V1C1, ATP6V0A2, and ATP6V1D. These ATPases are proton pumps which can 
generate H+ by using ATP. In addition, several carbonic anhydrases are also 
up-regulated including CA1, CA2, and CA4. Carbonic anhydrases can catalyze H2CO3 
formation from CO2 and H2O. Thus, acidosis can result during the attack of unstable 
angina.  
 
Coagulation gene up-regulation during unstable angina 
 
In table 12, majority of coagulation related genes are up-regulated in peripheral 
leukocytes of unstable angina patients. These genes include THBS1, VWF, THBD, F2R, 
F5, F8, F2RL1, ITGA2B, PROS1, GP5, PTAFR, PLAUR, TFP1, ITGB3, PDGFD, HPSE, GP6, 
PEAR1, and TBXAS1. Only few coagulation related genes are down-regulated 
including GP1BB and CD36. Most important of all, F2RL1 is 18 fold up-regulated.  
 
RBC related genes are up-regulated during unstable angina 
 
In table 13, majority of RBC related genes are up-regulated during unstable angina. 
These up-regulated genes include EPB41, GYPE, ANK1, HP/HPP, NFE2, ALAS2, GYPA, 
HBG1/HBG2, EPOR, RHCE/RHD, ANKRD12, GYPB, HEBP1, ERAF, HBQ1, AK2RIN2, 
ANKRDS2, HEMGN, ANKRD50, HBM, and HBD. A few genes are down-regulated 
including HMOX1 and ANKRD10. It is worth noting that many hemoglobin genes are 
up-regulated including HBG1, HBG2, HBQ1, HBM, and HBD. Among them, HBG1/2 is 
20 fold up-regulated, HBM is 60 fold up-regulated, HEMGN is 49 fold up-regulated, 
HBQ1 is 18 fold up-regulated, ERAF is 33 fold up-regulated, GYPA is 27 fold 
up-regulated, and ALAS2 is 36 fold up-regulated. Heme oxygenase (HMOX1) can 
degrade heme and it is down-regulated in unstable angina.  
 
Discussion 
 
Atherosclerosis is a very common and detrimental disease, especially in many 
developed countries. It is usually among the top three leading causes of mortality. 
Inflammatory process is thought to be related to the etiology of atherosclerosis. C 
reactive protein (CRP) is found to be related to the course of atherosclerosis. 
Abnormal T cell activation has been found in atherosclerosis.(Liuzzo, Kopecky et al. 
1999) However, detailed relationship between inflammation and atherosclerosis is 
remained to be unlocked. Unstable angina is a clinical manifested syndrome of 
atherosclerosis. Thus, I use microarray analysis of peripheral leukocytes to study the 
relationship of specific inflammation and unstable angina.  
 
Host immunity against bacteria includes TH1(anti-intracellular bacteria) and 
TH17(anti-extracellular bacteria). It is observed that Chlamydia pneumonia is noted 
in endothelium of atherosclerosis lesion(Benagiano, Azzurri et al. 2003, Benagiano, 
Munari et al. 2012). Thus, immunity against intracellular bacteria is likely to be 
activated in atherosclerosis. In addition, Helicobacter pylori infection is also related 
to atherosclerosis. Thus, anti-extracellular TH17 immunity is also likely to be 
activated during atherosclerosis(Ng, Burris et al. 2011). In addition, TH1 and TH17 
immunological pathways are also related to important risk factors for atherosclerosis: 
Diabetes mellitus and hypertension.(Gao, Jiang et al. 2010, Xie, Wang et al. 2010) In 
addition, CRP, the TH17 inflammatory factor, is elevated in atherosclerosis. 
Macrophage, the main TH1 effector cell, is accumulated in atherosclerotic 
plaques(Laurat, Poirier et al. 2001). In addition, deficiency of Treg cells promotes the 
progression of atherosclerosis.(Gotsman, Grabie et al. 2006, Mor, Planer et al. 2007) 
Besides, TH2 and THαβ immunological pathway activation such as IL-10 
up-regulation can reduce the development of atherosclerosis.(Liuzzo, Kopecky et al. 
1999, Pinderski 2002) These evidences all suggest that TH1 and TH17 immunity plays 
an important role in the pathophysiology of atherosclerosis.  
 
In this study, I find out the evidences that immunity plays a very important role in the 
pathogenesis of unstable angina. First of all, anti-bacterial Toll-like receptors are 
up-regulated during unstable angina. These Toll-like receptors include TLR 1,2,4,6,8. 
It is worth noting that TLR 1,2,4,6 are for triggering anti-extracellular bacteria TH17 
immunity. TLR8 is for triggering anti-intracellular bacteria TH1 immunity. Thus, both 
TH1 and TH17 immunity are initiated during unstable angina.  
 
In addition, heat shock proteins which are responsible for triggering anti-bacterial 
immunity are also up-regulated during unstable angina attack. Heat shock protein 70 
(HSP70) can bind to Toll-like receptor 2 and Toll-like receptor 4 to trigger TH17 
immunity. In this study, I find out that HSP70 genes are up-regulated including 
HSPA1A, HSPA6, and HSPA13. This means anti-bacterial immunity is activated during 
unstable angina.  
 
Then, we look at immune-related transcription factor expression in unstable angina. 
Strikingly, we find out many TH1 and TH17 related immune transcription factor 
up-regulation in unstable angina patients’ peripheral leukocytes. STAT1 is the key 
downstream transcription factor of TH1 immunity. The key TH1 cytokine, IFN gamma, 
can mediate its function mainly by activating STAT1. In addition, STAT5B and SMAD 
proteins are major effector genes of TGF beta signaling. TGF beta is the key cytokine 
to initiate TH17 immunity. Thus, both TH1 and TH17 are likely to be activated during 
unstable angina. In addition, TH17 negative regulator, ETS1, is down-regulated in 
unstable angina(Moisan, Grenningloh et al. 2007). Retinoic acid related transcription 
factors, which promote TH1 and TH17 immunity, are up-regulated during unstable 
angina.(Mucida, Park et al. 2007) Aiolos(IKZF3), which can activate TH17 immunity, is 
also up-regulated in unstable angina.(Quintana, Jin et al. 2012)  
 
Chemokine genes are differentially regulated in unstable angina. Most important of 
all, TH17 and TH1 related chemokine and chemokine receptor genes are 
up-regulated. These strikingly up-regulated chemokine related genes include CXCL1, 
CCR3, CXCL5, IL8RB, and S100P. CCR3 is TH1 immunity related chemokine receptor. 
CXCL1, CXCL5, and S100P are TH17 immunity related chemokines. And, IL8RB is TH17 
related chemokine receptor. Besides, prostaglandin and leukotriene B4 related genes 
are also up-regulated during unstable angina. This also shows that TH17 
anti-bacterial immunity is activated at unstable angina. 
 
Then, we look at cytokine and cytokine receptor gene expression profiles of 
peripheral leukocytes during unstable angina. We find out that IL-18, TGFA, IFNG, 
IL1B, and IL8 are up-regulated. Among them, IL-18, TGFA, and IFNG are key TH1 
related cytokines. IL8 and IL1B are key TH17 related cytokines. Besides, many 
cytokine receptors are also differentially regulated at unstable angina. These 
up-regulated cytokine receptors include IL-1R, IL-13R, IL-5R, IL10R, IFNaR, IL1R, and 
TGFB1R. And, down-regulated cytokine receptors are IL6ST and IFNgR. Specific 
immunological pathway is usually associated with down-regulation of its effector 
cytokine receptors. Thus, TH1 activation is related to interferon gamma receptor 
down-regulation, and TH17 activation is related to interleukin 6 receptor 
down-regulation. In addition, TH2, THαβ, Treg, and TH22 immune pathways are not 
triggered. These results also support my hypothesis.  
 
Complements are important in mediating host killing of intracellular bacteria as well 
as extracellular bacteria. In this study, we can see that majority of complement 
machinery is activated including CD59, CD55, CFD, C4BPA, CR1, C4A/B, CD46, C1QBP, 
ITGAX, C1RL, C5AR1, and CR1/1L. This means anti-bacterial TH1 or TH17 immunity is 
triggered during unstable angina. Besides, other important anti-bacterial host 
defense genes are also up-regulated. These up-regulated anti-bacterial genes include 
CSF3R, FPR1, CSF2RB, SCARF1, CSF2RA, DEFA4, NCF4, NCF2, FPR2, MRC2, DEFB106A, 
and PTX3. These genes include neutrophil and macrophage growth factors, pattern 
recognition receptor, defensin, neutrophil cytosolic factors, and pentraxin. These all 
suggest that TH1 or TH17 anti-bacterial immunity is activated during unstable angina. 
 
By using microarray analysis, we can also understand the complications of unstable 
angina. Glycolysis, acidosis, hypoxia, and coagulation anomaly are frequently 
reported in unstable angina. First of all, we look at the glycolytic mediating enzymes 
in unstable angina. Strikingly, we find out all glycolytic enzyme genes are 
up-regulated including PGK1, PFKFB3, HK2, PYGL, BPGM, PDK3, PFKFB2, GAPDH, 
ENO1, PDK2, PDK4, PGK1, and PFKFB4. Among them, BPGM is 19 fold up-regulated. 
BPGM can help to unload oxygen from oxy-hemoglobins. Thus, it can help to alleviate 
the hypoxic syndrome during unstable angina. It can be explained as a host 
compensatory mechanism responding to the attack of unstable angina. More, we 
find out that many ATPase genes are up-regulated during unstable angina including 
ATP6V0B, ATP6V0C, ATP6V1B2, ATP6V0E1, ATP6AP2, ATP6V1A, ATP6V1C1, ATP6V0A2, 
and ATP6V1D. Several carbonic anhydrase enzyme genes are also up-regulated 
including CA1, CA2, and CA4. In my previous malaria genomic research, I find out a 
co-expression of glycolytic enzymes and ATPases. Here, I also find out acidosis at 
unstable angina can be due to up-regulation of these proton pumps (H+-ATPase) and 
H2CO3 producing carbonic anhydrases.  
 
Finally, we look at RBC and platelet related gene expression profiles during unstable 
angina. Strikingly, we find out that majority of RBC and platelet related genes are 
up-regulated during unstable angina. Up-regulated platelet/coagulation related 
genes include THBS1, VWF, THBD, F2R, F5, F8, F2RL1, ITGA2B, PROS1, GP5, PTAFR, 
PLAUR, TFP1, ITGB3, PDGFD, HPSE, GP6, PEAR1, and TBXAS1. Platelet function is 
triggering blood coagulation, and overactivation of coagulation related genes can be 
related to the pathophysiology of atherosclerosis induced unstable angina with 
coronary artery occlusion. Up-regulated RBC related genes include EPB41, GYPE, 
ANK1, HP/HPP, NFE2, ALAS2, GYPA, HBG1/HBG2, EPOR, RHCE/RHD, ANKRD12, GYPB, 
HEBP1, ERAF, HBQ1, AK2RIN2, ANKRDS2, HEMGN, ANKRD50, HBM, and HBD. We can 
see many hemoglobin genes are up-regulated at unstable angina. Unstable angina is 
caused by lack of oxygen support for cardiac muscle. Thus, up-regulated RBC related 
genes including hemoglobin genes can help to alleviate the hypoxia status during 
unstable angina. It can be viewed as a host compensatory mechanism at the attack of 
unstable angina. 
 
In summary, microarray analysis of peripheral leukocytes from unstable angina 
patients can help to explain the pathogenesis of unstable angina. From the above 
evidences, unstable angina can be viewed as a mix TH1 and TH17 inflammatory 
disorder with up-regulated TH1/TH17 chemokines, cytokines, transcription factors, 
Toll-like receptors, heat shock proteins, complements, leukotrienes, prostaglandins, 
defensins, pentraxins, and other effector molecules. In addition, overactivation of 
platelet related genes, glycolytic enzymes, and H+-ATPases can help to explain the 
pathophysiology of unstable angina with coagulation hyperactivity and metabolic 
acidosis. Finally, up-regulation of RBC related genes should be a host compensatory 
mechanism to increase oxygen delivery during unstable angina. 
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Figure legends 
 
Figure 1. RMA express plot for selecting samples in normal healthy controls. 
1-A NUSE boxplot for normal control 
1-B RLE boxplot for normal control 
1-C RLE-NUSE multiplot for normal control 
1-D RLE-NUSE T2 plot for normal control 
 
Figure 2. RMA express plot for selecting samples in unstable angina patients. 
2-A NUSE boxplot for unstable angina patients 
2-B RLE boxplot for unstable angina patients 
2-C RLE-NUSE multiplot for unstable angina patients 
2-D RLE-NUSE T2 plot for unstable angina patients 
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Table 1. 
Toll-like-receptor 
   Probe Set ID Pvalue Arrow Fold Gene 
204924_at 6.07E-05 up 2.711394 TLR2 
207446_at 1.82E-06 up 2.196196 TLR6 
210176_at 1.61E-09 up 7.237305 TLR1 
220832_at 1.16E-08 up 6.489917 TLR8 
221060_s_at 6.35E-07 up 5.706266 TLR4 
224341_x_at 5.14E-06 up 5.151984 TLR4 
229560_at 6.43E-05 up 3.756611 TLR8 
232068_s_at 2.04E-10 up 13.17082 TLR4 
1552798_a_at 7.63E-07 up 3.467543 TLR4 
202266_at 1.91E-07 up 2.636574 TTRAP 
209451_at 5.11E-09 up 5.10644 TANK 
210458_s_at 2.56E-10 up 6.495119 TANK 
211828_s_at 1.66E-08 down -2.46097 TNIK 
217930_s_at 8.09E-10 up 3.414113 TOLLIP 
239431_at 1.01E-05 up 2.18973 TICAM2 
1552360_a_at 1.28E-09 up 2.909597 TIRAP 
213817_at 6.28E-04 up 2.556772 IRAK3 
205558_at 2.29E-09 up 2.273412 TRAF6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Heat shock protein 
  Probe Set ID Pvalue Arrow Fold Gene 
211968_s_at 5.02E-09 down -3.03611 HSP90AA1 
213418_at 1.09E-04 up 2.462545 HSPA6 
117_at 2.01E-06 up 3.369852 HSPA6 
200799_at 1.78E-05 up 2.131275 HSPA1A 
200800_s_at 7.79E-05 up 2.27759 HSPA1A/B 
202557_at 1.48E-05 up 2.020725 HSPA13 
202581_at 7.23E-10 up 5.616055 HSPA1A/B 
203960_s_at 1.04E-05 up 2.114942 HSPB11 
1554333_at 4.79E-05 up 4.757214 DNAJA4 
1554334_a_at 2.40E-04 up 3.128753 DNAJA4 
1554462_a_at 6.27E-08 up 2.534985 DNAJB9 
1558080_s_at 2.64E-06 down -3.33239 DNAJC3 
202416_at 1.77E-09 down -2.93756 DNAJC7 
202500_at 6.74E-09 up 3.785045 DNAJB2 
202842_s_at 1.22E-06 up 2.269558 DNAJB9 
202843_at 5.11E-09 up 2.767084 DNAJB9 
203810_at 4.20E-08 up 2.99098 DNAJB4 
204720_s_at 2.13E-06 up 4.809938 DNAJC6 
208810_at 8.05E-09 up 2.512607 DNAJB6 
208811_s_at 1.66E-06 up 2.526036 DNAJB6 
209015_s_at 2.35E-07 up 2.843226 DNAJB6 
209157_at 3.03E-08 up 2.647895 DNAJA2 
213097_s_at 3.59E-10 down -2.68168 DNAJC2 
222620_s_at 5.74E-07 down -2.89806 DNAJC1 
223504_at 2.84E-05 up 2.296595 DNAJC27 
225061_at 1.83E-04 up 3.17514 DNAJA4 
225284_at 4.93E-05 up 2.162836 DNAJC3 
226859_at 5.59E-09 up 2.031987 DNAJC25 
226994_at 2.89E-07 up 2.197155 DNAJA2 
 
 
 
 
 
 
 
Table 3. Transcription factors 
  Probe Set ID Pvalue Arrow Fold Gene 
M97935_MB_at 5.29E-06 up 3.250345 STAT1 
201328_at 8.13E-06 up 2.391284 ETS2 
201329_s_at 2.07E-04 up 2.834679 ETS2 
202527_s_at 2.47E-08 up 3.925728 SMAD4 
203077_s_at 2.05E-09 up 2.499254 SMAD2 
203140_at 2.67E-08 up 4.672891 BCL6 
203275_at 3.53E-10 up 2.53243 IRF2 
203749_s_at 1.45E-09 up 2.776926 RARA 
204131_s_at 3.18E-07 up 5.362668 FOXO3 
204132_s_at 7.42E-10 up 9.790864 FOXO3/B 
204790_at 3.32E-06 up 2.693902 SMAD7 
205841_at 8.44E-05 up 2.228473 JAK2 
210655_s_at 2.51E-08 up 6.194851 FOXO3/B 
211027_s_at 1.09E-07 down -2.20832 IKBKB 
212550_at 7.95E-10 up 2.703492 STAT5B 
214447_at 2.18E-06 down -2.71117 ETS1 
217804_s_at 7.97E-10 down -2.29951 ILF3 
218880_at 2.81E-07 up 2.718907 FOSL2 
222670_s_at 7.29E-04 down -2.03266 MAFB 
223287_s_at 8.80E-09 down -4.59015 FOXP1 
224889_at 1.75E-10 up 8.903059 FOXO3 
224891_at 3.03E-07 up 4.554951 FOXO3 
225223_at 1.74E-06 up 2.836291 SMAD5 
225262_at 0.018247 up 2.013291 FOSL2 
227798_at 1.70E-05 up 2.374207 SMAD1 
228026_at 1.18E-06 up 3.017289 RP5-1000E10.4 
228188_at 5.50E-07 up 4.339457 FOSL2 
228758_at 1.45E-05 up 3.365109 BCL6 
240613_at 4.95E-10 down -6.16447 JAK1 
1552611_a_at 2.95E-05 up 2.774677 JAK1 
1565703_at 1.20E-06 up 2.179628 SMAD4 
204959_at 1.12E-06 up 5.577443 MNDA 
210029_at 1.19E-05 up 3.981845 IDO1 
211027_s_at 1.09E-07 down -2.20832 IKBKB 
214105_at 7.95E-08 down -2.10317 SOCS3 
221092_at 8.50E-04 up 2.294967 IKZF3 
223287_s_at 8.80E-09 down -4.59015 FOXP1 
223937_at 5.84E-07 down -2.23877 FOXP1 
225223_at 1.74E-06 up 2.836291 SMAD5 
225673_at 1.62E-06 up 2.660096 MYADM 
202426_s_at 5.52E-11 up 7.436708 RXRA 
228026_at 1.18E-06 up 3.017289 RP5-1000E10.4 
235444_at 2.78E-08 down -2.21648 FOXP1 
244523_at 7.85E-07 up 2.832237 MMD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4 Chemokine 
   Probe Set ID Pvalue Arrow Fold Gene 
204470_at 4.05E-11 up 7.821242 CXCL1 
205098_at 1.50E-05 up 3.999256 CCR1 
205099_s_at 0.001392 up 2.339561 CCR1 
206336_at 4.69E-10 up 3.787778 CXCL6 
206337_at 2.90E-06 down -2.92756 CCR7 
206978_at 0.011513 up 2.081589 CCR2 
206983_at 1.38E-04 up 2.189831 CCR6 
207794_at 0.00177 up 2.296914 CCR2 
208304_at 4.74E-11 up 17.6996 CCR3 
208335_s_at 2.21E-06 up 3.161269 DARC 
210548_at 0.001164 up 2.080932 CCL23 
211434_s_at 1.17E-05 up 2.202749 CCRL2 
212977_at 8.10E-06 up 2.406206 CXCR7 
214974_x_at 2.32E-06 up 7.833923 CXCL5 
215101_s_at 2.78E-06 up 8.043318 CXCL5 
219161_s_at 4.00E-11 up 5.634878 CKLF 
221058_s_at 1.44E-08 up 2.639918 CKLF 
223451_s_at 7.77E-11 up 4.474447 CKLF 
223454_at 4.20E-06 up 3.074875 CXCL16 
1568934_at 2.01E-06 up 2.647086 CX3CR1 
204470_at 4.05E-11 up 7.821242 CXCL1 
207008_at 1.99E-12 up 38.26742 IL8RB 
207094_at 1.25E-14 up 12.5119 IL8RA 
211506_s_at 3.18E-04 up 2.965578 IL8 
202859_x_at 0.02858 up 2.698248 IL8 
208540_x_at 2.08E-06 up 2.709116 S100A11/P 
209686_at 0.022845 up 2.555998 S100B 
238909_at 5.34E-06 down -2.86673 S100A10 
203535_at 4.97E-06 up 3.946168 S100A9 
204351_at 5.64E-10 up 50.28864 S100P 
205863_at 1.63E-04 up 4.381631 S100A12 
 
 
 
 
 
Table 5 Prostaglandin/leukotriene 
 Probe Set ID Pvalue Arrow Fold Gene 
211548_s_at 4.79E-08 up 3.603627 HPGD 
211549_s_at 1.36E-05 up 2.012863 HPGD 
238669_at 2.01E-04 up 2.296154 PTGS1 
1554997_a_at 9.37E-04 up 3.008369 PTGS2 
203913_s_at 4.41E-09 up 4.03641 HPGD 
203914_x_at 2.93E-07 up 3.450221 HPGD 
204748_at 8.71E-06 up 7.748884 PTGS2 
236172_at 1.25E-09 up 3.392918 LTB4R 
204174_at 1.11E-10 up 7.512037 ALOX5AP 
204446_s_at 2.35E-06 up 2.195747 ALOX5 
207206_s_at 3.90E-05 up 2.604373 ALOX12 
214366_s_at 2.90E-04 up 2.121638 ALOX5 
221027_s_at 0.00175 up 2.000762 PLA2G12A 
228084_at 4.11E-04 up 2.14738 PLA2G12A 
235394_at 9.50E-06 up 2.173632 PLAA 
242323_at 5.76E-07 up 2.319156 PLA2G12A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6. Cytokine 
   Probe Set ID Pvalue Arrow Fold Gene 
237046_x_at 4.92E-08 down -2.01547 IL34 
1568513_x_at 5.20E-07 down -3.14638 IL23A 
202859_x_at 0.02858 up 2.698248 IL8 
203828_s_at 2.70E-07 down -4.22368 IL32 
205067_at 2.91E-09 up 11.1993 IL1B 
206295_at 2.08E-07 up 2.190391 IL18 
39402_at 3.79E-08 up 9.375368 IL1B 
203085_s_at 2.46E-12 down -4.47642 TGFB1 
209651_at 1.04E-05 up 3.862509 TGFB1I1 
205016_at 3.08E-13 up 12.56279 TGFA 
210354_at 4.89E-05 up 2.295556 IFNG 
230681_at 3.27E-05 down -2.09638 TBRG1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7. Cytokine receptor 
  Probe Set ID Pvalue Arrow Fold Gene 
239522_at 1.63E-07 down -2.13821 IL12RB1 
201887_at 2.63E-04 up 2.493641 IL13RA1 
201888_s_at 3.50E-07 up 5.265817 IL13RA1 
202948_at 3.01E-13 up 10.59575 IL1R1 
204116_at 1.72E-13 down -4.5043 IL2RG 
205403_at 1.14E-14 up 37.11373 IL1R2 
205798_at 0.001876 down -2.04842 IL7R 
206618_at 3.97E-05 up 2.889916 IL18R1 
209575_at 6.50E-10 up 3.094987 IL10RB 
210744_s_at 5.37E-04 up 2.377707 IL5RA 
210904_s_at 6.93E-13 up 10.38528 IL13RA1 
211372_s_at 8.57E-13 up 23.53884 IL1R2 
211517_s_at 0.001136 up 2.419155 IL5RA 
211612_s_at 5.00E-09 up 8.944053 IL13RA1 
212196_at 9.43E-05 down -2.08387 IL6ST 
226333_at 4.08E-13 up 2.730188 IL6R 
224793_s_at 4.59E-05 up 2.229928 TGFBR1 
225661_at 1.28E-12 up 5.958052 IFNAR1 
225669_at 8.99E-08 up 3.14582 IFNAR1 
204191_at 2.17E-07 up 2.336802 IFNAR1 
242903_at 1.66E-09 down -10.0312 IFNGR1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 8. Complement 
   Probe Set ID Pvalue Arrow Fold Gene 
200983_x_at 2.01E-10 up 5.126428 CD59 
200984_s_at 3.96E-10 up 5.39977 CD59 
200985_s_at 7.88E-08 up 3.902797 CD59 
201925_s_at 5.64E-10 up 4.165688 CD55 
201926_s_at 7.26E-08 up 2.685217 CD55 
205382_s_at 3.05E-04 up 3.283973 CFD 
205654_at 0.025737 up 2.728636 C4BPA 
206244_at 1.59E-08 up 5.148756 CR1 
208451_s_at 1.33E-05 up 3.146097 C4A/4B 
208488_s_at 2.21E-06 up 2.838257 CR1 
208783_s_at 4.44E-10 up 2.762472 CD46 
208910_s_at 8.91E-07 up 2.772785 C1QBP 
210184_at 3.36E-07 up 2.689394 ITGAX 
212463_at 2.39E-08 up 2.387086 CD59 
217552_x_at 1.26E-08 up 5.06804 CR1 
218232_at 0.001617 down -2.31401 C1QA 
218983_at 5.79E-11 up 4.443039 C1RL 
220088_at 6.89E-05 up 4.115375 C5AR1 
239205_s_at 5.31E-11 up 15.49001 CR1/1L 
239206_at 2.42E-09 up 12.87955 CR1L 
244313_at 8.98E-10 up 9.401143 CR1 
1555950_a_at 8.18E-09 up 3.116447 CD55 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 9 anti-bacterial genes 
  Probe Set ID Pvalue Arrow Fold Gene 
203591_s_at 5.40E-05 up 2.953523 CSF3R 
205118_at 1.40E-06 up 6.013851 FPR1 
205119_s_at 1.17E-07 up 8.646483 FPR1 
205159_at 4.60E-08 up 10.71302 CSF2RB 
206995_x_at 9.73E-09 up 5.092197 SCARF1 
207085_x_at 1.37E-06 up 3.863292 CSF2RA 
207269_at 9.38E-06 up 11.51901 DEFA4 
207677_s_at 4.04E-08 up 5.465464 NCF4 
209949_at 2.90E-05 up 2.761298 NCF2 
210340_s_at 2.92E-06 up 3.513592 CSF2RA 
210772_at 3.39E-13 up 38.75074 FPR2 
210773_s_at 1.67E-11 up 22.8151 FPR2 
211287_x_at 5.85E-07 up 2.873763 CSF2RA 
37408_at 1.83E-05 up 2.611298 MRC2 
1552411_at 1.45E-06 up 2.029896 DEFB106A/B 
1553297_a_at 1.38E-05 up 2.481309 CSF3R 
206157_at 9.63E-08 up 3.038519 PTX3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 10 Glycolytic enzymes 
  Probe Set ID Pvalue Arrow Fold Gene 
217356_s_at 1.45E-07 up 3.485421 PGK1 
202464_s_at 1.88E-05 up 3.848975 PFKFB3 
202934_at 7.47E-04 up 2.054129 HK2 
202990_at 4.01E-07 up 4.853299 PYGL 
203502_at 2.42E-08 up 19.10826 BPGM 
206348_s_at 4.04E-08 up 2.488083 PDK3 
209992_at 1.30E-07 up 2.552616 PFKFB2 
M33197_5_at 4.35E-06 up 2.191367 GAPDH 
217294_s_at 9.10E-05 up 3.210724 ENO1 
217356_s_at 1.45E-07 up 3.485421 PGK1 
213724_s_at 2.15E-05 up 2.269032 PDK2 
225207_at 0.04755 up 2.020549 PDK4 
227068_at 5.94E-05 up 2.026827 PGK1 
228499_at 1.41E-06 up 2.453812 PFKFB4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table11 ATPase 
   Probe Set ID Pvalue Arrow Fold Gene 
200078_s_at 1.87E-05 up 2.165182 ATP6V0B 
200954_at 7.36E-08 up 3.458313 ATP6V0C 
201089_at 2.00E-05 up 3.342557 ATP6V1B2 
201171_at 2.74E-08 up 3.750572 ATP6V0E1 
201444_s_at 8.20E-06 up 2.14297 ATP6AP2 
201971_s_at 4.37E-04 up 2.028055 ATP6V1A 
202872_at 1.07E-10 up 6.460473 ATP6V1C1 
202874_s_at 2.48E-10 up 4.5579 ATP6V1C1 
205704_s_at 3.66E-05 up 2.185279 ATP6V0A2 
208898_at 5.55E-05 up 2.130803 ATP6V1D 
208899_x_at 3.59E-08 up 2.716261 ATP6V1D 
214149_s_at 8.54E-11 up 7.664084 ATP6V0E1 
36994_at 4.81E-09 up 2.599531 ATP6V0C 
205950_s_at 5.00E-08 up 42.28005 CA1 
206208_at 2.02E-09 up 3.94974 CA4 
206209_s_at 1.82E-12 up 8.938537 CA4 
209301_at 2.90E-04 up 2.461168 CA2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 12. Coagulation genes 
  Probe Set ID Pvalue Arrow Fold Gene 
201108_s_at 2.84E-05 up 3.303681 THBS1 
201109_s_at 7.13E-05 up 2.95573 THBS1 
201110_s_at 5.89E-08 up 6.730528 THBS1 
202112_at 8.64E-07 up 2.154882 VWF 
203887_s_at 2.66E-10 up 13.1587 THBD 
203888_at 1.55E-09 up 5.29251 THBD 
203989_x_at 3.03E-05 up 3.24114 F2R 
204713_s_at 3.02E-06 up 2.665104 F5 
204714_s_at 2.58E-06 up 3.393421 F5 
205756_s_at 1.71E-07 up 2.887461 F8 
206429_at 4.35E-06 up 2.168341 F2RL1 
206493_at 0.012261 up 2.018667 ITGA2B 
207808_s_at 6.13E-06 up 3.830064 PROS1 
207815_at 9.67E-06 up 8.676992 PF4V1 
207926_at 1.53E-05 up 2.539035 GP5 
209769_s_at 1.05E-08 down -2.30101 GP1BB 
211661_x_at 1.44E-06 up 5.09946 PTAFR 
211924_s_at 1.35E-07 up 4.396324 PLAUR 
213258_at 9.09E-06 up 3.442621 TFPI 
213506_at 1.11E-10 up 18.07023 F2RL1 
214866_at 5.24E-08 up 3.066191 PLAUR 
215240_at 1.86E-07 up 4.259491 ITGB3 
219304_s_at 0.001786 up 2.10823 PDGFD 
219403_s_at 0.002328 up 2.352545 HPSE 
220336_s_at 3.37E-04 up 2.506245 GP6 
222881_at 1.96E-06 up 2.9733 HPSE 
228618_at 2.78E-05 up 2.611937 PEAR1 
231029_at 2.14E-09 up 4.807453 F5 
236345_at 1.63E-13 up 8.191023 TBXAS1 
237252_at 1.11E-05 up 2.237747 THBD 
242197_x_at 6.23E-05 down -4.4414 CD36 
 
 
 
 
 
Table 13 RBC genes 
   Probe Set ID Pvalue Arrow Fold Gene 
207793_s_at 5.29E-06 up 3.527715 EPB41 
207854_at 5.69E-04 up 2.700479 GYPE 
208352_x_at 5.02E-08 up 5.233521 ANK1 
208353_x_at 1.46E-08 up 8.199239 ANK1 
208470_s_at 4.92E-04 up 2.42323 HP /// HPR 
209930_s_at 7.44E-07 up 6.157681 NFE2 
211560_s_at 5.08E-08 up 36.1193 ALAS2 
211820_x_at 5.24E-10 up 17.19674 GYPA 
211821_x_at 5.49E-09 up 27.56794 GYPA 
213515_x_at 8.72E-07 up 13.31291 HBG1 /// HBG2 
215054_at 4.51E-10 up 3.067622 EPOR 
37986_at 2.17E-09 up 2.737781 EPOR 
215819_s_at 1.12E-07 up 4.649047 RHCE /// RHD 
216317_x_at 0.001298 up 2.167189 RHCE 
216563_at 3.75E-05 up 2.423975 ANKRD12 
216833_x_at 1.03E-06 up 7.30822 GYPB /// GYPE 
218450_at 1.29E-04 up 2.919147 HEBP1 
203665_at 1.99E-04 down -2.47673 HMOX1 
219672_at 1.22E-08 up 33.80057 ERAF 
220807_at 2.56E-10 up 18.14282 HBQ1 
223143_s_at 0.001106 up 2.024285 AKIRIN2 
223542_at 4.16E-06 up 2.408006 ANKRD32 
223669_at 9.14E-08 up 20.2901 HEMGN 
223670_s_at 4.73E-11 up 49.78136 HEMGN 
225051_at 6.51E-05 up 2.198623 EPB41 
225735_at 1.10E-06 up 2.178783 ANKRD50 
226663_at 5.93E-06 down -2.50174 ANKRD10 
240336_at 3.15E-12 up 61.68572 HBM 
1554481_a_at 4.42E-06 up 5.047096 EPB41 
204419_x_at 3.33E-06 up 20.09402 HBG1 /// HBG2 
204848_x_at 1.85E-06 up 17.25642 HBG1 /// HBG2 
206834_at 0.011457 up 3.600573 HBD 
213515_x_at 8.72E-07 up 13.31291 HBG1 /// HBG2 
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